Is Aurora Cannabis Inc (TSX:ACB) Working on a Big Deal?

Aurora Cannabis Inc (TSX:ACB)(NYSE:ACB) has been bringing on some key executive on board lately that know a thing or two about mergers and acquisitions.

| More on:
Business people shaking hands

Image source: Getty Images

Aurora Cannabis (TSX:ACB)(NYSE:ACB) has been making some big, subtle moves lately.

In March, the company announced that it was bringing on billionaire investor Nelson Peltz as a strategic advisor. Normally, that’s a vague position and can mean anything and everything. However, in this case, it was noticeably different. For one, Peltz could end up being a big shareholder of the company, as he could end up with options to potentially purchase nearly 20 million shares of Aurora.

And from Aurora’s press release, his mandate appears clear: find potential deals. The company stated, “Mr. Peltz and Aurora will work collaboratively and strategically to explore potential partnerships that would be the optimal strategic fit for successful entry into each of Aurora’s contemplated market segments.”

With those kinds of goals and that kind of compensation, you can bet this is not your typical advisor position. This is a well-connected individual that has worked with some big-name companies. He has the type of connections that would help Aurora gain insight into potential deals.

Big banking experience added as well

Aurora also brought on another key executive into the mix: Carey Squires. The company created a new position for Squires, executive vice president of corporate development and strategy. Here again, Aurora noted in the press release, “Mr. Squires in collaboration with senior executives across the company will focus on global growth and partnership strategies and investor development.”

The company also specifically noted that he would be working on “partnerships and M&A opportunities.” Having worked for BMO Capital Markets, he knows a great deal about acquisitions and valuations.

All the ingredients are there for Aurora to make a big splash

With Peltz offering the connections and business insights to help find a potential partner and Squires adding the oversight and focus on valuation, Aurora looks like it has a solid one-two punch of advisors that could help steer the company into what could be a significant deal. While cannabis companies haven’t been the most frugal, bringing big names like this on board are going to drive expectations from investors, and Aurora knows that.

The company has been in the sidelines, while its peers have been finding deals and the stakes are getting higher as we approach the legalization of edibles later this year. And given the pedigree of the individuals that Aurora has brought on board and even creating a new position for one of them, I’m inclined to believe Aurora isn’t content with a small partner; it’s looking to rock the industry with a massive deal.

There were rumours last year of the Aurora being in talks with Coca-Cola, although nothing came of that. Unfortunately, it may not be able to get a company of that size on board today, especially with the legal obstacles in the U.S. providing impediments for some of the bigger players. However, if Aurora truly wants to rival Canopy Growth, it’s going to need to swing for the fences, which is what I think the company is trying to do by bringing in some heavy hitters into its lineup.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor David Jagielski has no position in any of the stocks mentioned.

More on Cannabis Stocks

edit Jars of marijuana
Cannabis Stocks

Is Tilray Stock a Buy in the New Bullish Market?

Canadian cannabis producer Tilray has underperformed the broader markets in the last five years due to its weak fundamentals.

Read more »

Bad apple with good apples
Cannabis Stocks

1 TSX Stock I Wouldn’t Touch With a 10-Foot Pole

Down 99% from all-time highs, Aurora Cannabis stock remains a high-risk bet due to its weak fundamentals and risky liquidity…

Read more »

A cannabis plant grows.
Cannabis Stocks

Canopy Growth Stock Has Been on a Roller Coaster: Is it a Good Buy?

In their relatively small lifetime, most cannabis stocks in Canada have seen both extreme highs and massive slumps. But their…

Read more »

Medicinal research is conducted on cannabis.
Cannabis Stocks

Canopy Growth Stock Surged 100% Last Month: Is It a Good Buy Now?

Canopy Growth soared more than 160% last month. Can the TSX cannabis stock continue to mover higher in 2024?

Read more »

A cannabis plant grows.
Cannabis Stocks

Canopy Growth Stock Is Rising But I’m Worried About This One Thing

Canopy Growth stock is soaring as the legalization effort makes real progress in both Germany and the United States.

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

Why Canopy Growth Stock Could Double in 2024

Canopy Growth (TSX:WEED) stock saw its share more than double in the last two weeks. So, can it do it…

Read more »

Coworkers standing near a wall
Cannabis Stocks

Why Is Everyone Talking About Canopy Growth Stock?

Canopy Growth stock (TSX:WEED) saw shares surge in the last two weeks for a variety of reasons investors can dig…

Read more »

Pot stocks are a riskier investment
Stocks for Beginners

Why Shares of Cannabis Stocks Are Rising This Week

Cannabis stocks received a boost this week as the White House urged the drug enforcement administration to reschedule the drug.

Read more »